By analyzing the relationship between prognosis and GOT2 mRNA expression levels in patients with hepatocellular carcinoma in the TCGA database, we found that patients with low GOT2 expression had a worse prognosis in the TCGA database (Fig. 9A). Here, GOT2 is linked to hepatocellular carcinoma.